Insider · CIK 0001643746

Kim Lorence H.

Reports to the SEC for 5 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001643746

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-08	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−706 sh	$206.60	−$146K	16,384
2026-09-08	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−4,730 sh	$210.50	−$996K	4,215
2026-09-08	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−371 sh	$212.27	−$78.8K	0
2026-09-08	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−3,844 sh	$211.36	−$812K	371
2026-09-08	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−3,587 sh	$208.55	−$748K	11,798
2026-09-08	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−999 sh	$207.33	−$207K	15,385
2026-09-08	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−2,853 sh	$209.56	−$598K	8,945
2026-08-31	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−2,128 sh	$205.19	−$437K	17,715
2026-08-31	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−26.2K sh	$203.55	−$5.32M	27,114
2026-08-31	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−6,597 sh	$201.47	−$1.33M	66,193
2026-08-31	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−12.9K sh	$202.48	−$2.62M	53,274
2026-08-31	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−625 sh	$206.15	−$129K	17,090
2026-08-31	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−300 sh	$200.56	−$60.2K	72,790
2026-08-31	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−7,271 sh	$204.35	−$1.49M	19,843
2026-06-18	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+1,191 sh	—	—	74,281
2026-06-18	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,127 sh	—	—	3,127
2026-03-05	CORCencora, Inc.A Award	Director	AAward	+557 sh	$359.28	+$200K	4,081
2025-06-26	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+3,142 sh	—	—	73,090
2025-06-26	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.6K sh	—	—	11,574
2025-03-06	CORCencora, Inc.A Award	Director	AAward	+789 sh	—	—	3,524
2024-06-20	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	15,955
2024-06-20	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+4,248 sh	—	—	69,948
2024-06-20	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+4,800 sh	—	—	70,500
2024-06-20	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,700
2024-03-12	CORCencora, Inc.A Award	Director	AAward	+843 sh	—	—	2,735
2023-06-08	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+5,200 sh	—	—	65,700
2023-06-08	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,400
2023-03-09	CORCencora, Inc.A Award	Director	AAward	+1,334 sh	—	—	1,892
2023-03-01	COWEN INC.D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	$39.00	−$1.17M	0
2023-03-01	COWEN INC.D Disposition to Issuer	Director	DDisposition to Issuer	−8,236 sh	$39.00	−$321K	0
2022-11-01	CORCencora, Inc.A Award	Director	AAward	+558 sh	—	—	558
2022-08-30	COWEN INC.A Award	Director	AAward	+8,184 sh	—	—	38,184
2022-07-22	RVMDRevolution Medicines, Inc.P Purchase	Director	PPurchase	+50K sh	$20.00	+$1M	60,500
2022-07-12	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+36.8K sh	—	—	36,800
2022-07-12	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+10.5K sh	—	—	10,500
2022-02-25	COWEN INC.P Purchase	Director	PPurchase	+30K sh	$30.03	+$901K	30,000
2020-06-02	MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−66K sh	—	—	578,372
2020-06-02	MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−78.3K sh	—	—	587,735
2020-06-02	MRNAModerna, Inc.S Sale	Chief Financial Officer	SSale	−241K sh	$58.30	−$14.1M	1,202,510
2020-06-02	MRNAModerna, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+66K sh	$19.15	+$1.26M	1,346,850
2020-06-02	MRNAModerna, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+78.3K sh	$14.22	+$1.11M	1,280,819
2020-06-02	MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−96.7K sh	—	—	0
2020-06-02	MRNAModerna, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+96.7K sh	$19.15	+$1.85M	1,443,510
2020-05-27	MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−222K sh	—	—	666,044
2020-05-27	MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−18.6K sh	—	—	55,909
2020-05-27	MRNAModerna, Inc.S Sale	Chief Financial Officer	SSale	−241K sh	$51.13	−$12.3M	1,202,510
2020-05-27	MRNAModerna, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+18.6K sh	$12.21	+$228K	1,443,510
2020-05-27	MRNAModerna, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+222K sh	$14.22	+$3.16M	1,424,875
2020-05-18	MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−212K sh	—	—	74,544
2020-05-18	MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−29K sh	—	—	888,409

Recent filings

Accepted (ET)
Sep 104
Kim Lorence H.0001193125-26-388156
SEC(opens sec.gov)
Sep 24
Kim Lorence H.0001193125-26-380277
SEC(opens sec.gov)
Jun 234
Kim Lorence H.0001610717-26-000290
SEC(opens sec.gov)
Mar 94
Kim Lorence H.0001643746-26-000002
SEC(opens sec.gov)
Jun 304
Kim Lorence H.0001610717-25-000271
SEC(opens sec.gov)
Mar 104
Kim Lorence H.0001140859-25-000057
SEC(opens sec.gov)

Companies

Address

C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE

REDWOOD CITY, CA, 94063